Asymmetric Payoffs, Thracian Capital Management

Asymmetric Payoffs

Thracian Capital Management

FX & Rates

Japan has only one way to get out of its debt load— by completely devaluing its currency, which will happen sooner or later. But getting the timing right is very important, so you have to be very tactical on your entry points or buy cheap long-dated optionality, or both

Japan has only one way to get out of its debt load— by completely devaluing its currency, which will happen sooner or later. But getting the timing right is very important, so you have to be very tactical on your entry points or buy cheap long-dated optionality, or both

Long JYA Currency (Japanese Yen Future) Mar '17 86-Strike Puts at $0.26

Japan TMT Analyst

Pelham Smithers

Market Intel on Asian Tech with a Japan focus

Pelham Smithers Associates

Founded in 2009, Pelham Smithers Associates (PSA) provides market intelligence on Asian technology, focusing in particular on Japan. The industries covered by our team of specialists are: consumer electronics, telecomms, pharmaceuticals, internet, electronic parts and materials, automotive technology, retail and capital goods. 

Research is provided by the following:
Pelham Smithers: Macro, consumer electronics, telecoms & pharma
Joel Scheiman: Electronics materials / components
Julie Boote: Autos
Will Nestuk: Capital goods, machinery & transportation equipment parts
Thao Nguyen: eCommerce, internet content, marketing & advertising

Equity Bottom-Up

The announcement by the Japan Society of Medical Oncology (JSMO) urging patients to take caution over usage of immune checkpoint inhibitors, such as Opdivo, is entirely understandable in news that three of seven patients observed with interstitial lung disease following cancer treatment with Opdivo in combination therapy had died. However, it is unusual for the JSMO to act so quickly, and it is hard not to think that the government and costs are behind the announcement. In April, a cost estimate…

The announcement by the Japan Society of Medical Oncology (JSMO) urging patients to take caution over usage of immune checkpoint inhibitors, such as Opdivo, is entirely understandable in news that three of seven patients observed with interstitial lung disease following cancer treatment with Opdivo in combination therapy had died. However, it is unusual for the JSMO to act so quickly, and it is hard not to think that the government and costs are behind the announcement. In April, a cost estimate…

Ono & Opdivo: Is the Backlash Orchestrated?

Japan

WisdomTree Japan Hedged Equity Fund is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the WisdomTree Japan Hedged Equity Index. The Fund invests in dividend paying companies incorporated in Japan and listed on the Tokyo Stock Exchange, while neutralizing the risk of the Japanese yen's fluctuations relative to the USD.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Wisdomtree Japan Hedged Eq (DXJ US)

Long JYA Currency (Japanese Yen Future) Mar '17 86-Strike Puts at $0.26

Japan has only one way to get out of its debt load— by completely devaluing its currency, which will happen sooner or later. But getting the timing...

Asymmetric Payoffs

Ono & Opdivo: Is the Backlash Orchestrated?

The announcement by the Japan Society of Medical Oncology (JSMO) urging patients to take caution over usage of immune checkpoint inhibitors, such...

Pelham Smithers Associates

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)